$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Cell characterization and phenotyping are pivotal aspects of biomedical research1. Being able to characterize cells at both the morphological and molecular levels is paramount to understanding cell function, differentiation, and pathology1,2,3. It is particularly of interest in the field of oncology, where accurate cell profiling is necessary for tumor diagnosis, determining disease stage, and ultimately identifying therapeutic targets2. Traditional cell characterization methods cannot provide temporal dynamics and are usually based on invasive techniques, such as staining or labeling, which may interfere with the native state of the cells and introduce potential biases within the data4. Therefore, non-invasive strategies to provide accurate and thorough phenotyping of living cells, in their native, unperturbed state, are increasingly in demand.
In this context, label-free multimodal imaging methods have revolutionized cell biology research by combining complementary modalities to capture both morphological and molecular information2,5. These approaches allow for the integrated and non-invasive characterization of the cells that individual traditional techniques may not always be able to provide2,5,6. For instance, though microscopy techniques such as fluorescence microscopy have been widely used in morphological and functional cell imaging, they possess inherent limitations. Fluorescence methods often suffer from photobleaching, phototoxicity, and low quantities of targetable molecules, which restrict the analytical potential4. In addition, these approaches often require the use of exogenous labels or dyes, which may disrupt the native cell state or lead to artifacts7.
Multimodal imaging platforms, which combine the strengths of multiple imaging modalities, surpass these limitations by enabling the acquisition of different types of data from living cells without the need for labeling. The integration of Raman spectroscopy (RS) with other imaging modalities like phase contrast microscopy or tomographic phase microscopy (TPM) has been a promising strategy to overcome the limitations of single techniques. Indeed, multimodal imaging provides a deeper understanding of cellular phenotypes, especially in complex biological conditions and pathologies like cancer, where molecular and structural properties are crucial for accurate characterization2,5.
Label-free RS is well-suited for chemical imaging of cells8. By detecting molecular vibrational modes, RS provides biochemical fingerprints that can reveal in-depth information about the molecular composition of cells9,10,11. Raman spectra acquired from biological samples contain information about a variety of biomolecules such as lipids, proteins, nucleic acids, and metabolites, which play essential roles in understanding the molecular nature of cells9,12. One of the main strengths of RS is that it is non-invasive, allowing for the characterization of living cells in their natural state without altering their physiological condition.
Despite its many advantages, RS also presents some limitations. Indeed, although RS provides detailed molecular information, it does not allow for quantitative information on the morphology or structure of cells2. This is where complementary imaging techniques like TPM play a crucial role.
TPM is a form of quantitative phase imaging (QPI)13,14, and it enables the visualization of high-resolution, label-free quantitative information about cell morphology15,16. TPM differs from traditional microscopy techniques in that it does not require contrast agents; instead, it operates by measuring phase shifts resulting from variations in the refractive index (RI) of the sample17. Phase shifts provide information about the structural properties of the cell, including its volume, surface area, shape, and internal structure2,18. TPM can achieve high spatial resolution, to the nanometer level, and hence is an ideal technique for recording high-resolution morphological details of living cells. Further, the ability to reconstruct 3D RI tomograms makes it possible to visualize subcellular structures in their vivo environment18, providing more accurate information compared to 2D projections. However, one of the main limitations of TPM is its lack of chemical specificity, as it primarily provides information on the cell's morphology and phase distribution, without being able to differentiate between distinct chemical components or identify biochemical features.
The combination of RS and TPM in a multimodal technique provides advantages in cell phenotyping. While RS allows for rich molecular information, TPM adds a structural aspect, allowing cellular morphology to be analyzed in considerable detail. Recently, the combination of RS with TPM has been successfully demonstrated in several studies focused on cancer research2,19,20. For instance, previous work has reported that co-registering Raman spectroscopy with holographic phase microscopy data can provide complementary molecular and morphological information, allowing distinguishing among different cell types and tumor development stages2. These investigations have highlighted the power of multimodal imaging to enhance the accuracy of cell phenotyping, particularly in the context of cancer, where the molecular and structural characteristics of cells are closely linked to their malignancy and behavior2,20.
Despite the recent progress in multimodal imaging, there are still challenges to be addressed, particularly in data processing and analysis21. The large amounts of data that multimodal imaging techniques yield can be cumbersome to analyze, and straightforward procedures must be employed to extract meaningful information. To counter this challenge, user-friendly data processing pipelines must be established to handle the complexity of the data and minimize human bias in the analysis. Such pipelines are critical for the achievement of accuracy and reproducibility of the results and the possible translation of these approaches into clinical and diagnostic applications.
The goal of the present work is to illustrate the potential of merging RS with TPM for label-free, high-speed, and non-perturbative phenotyping of live single cancer cells. By merging these two robust imaging approaches, we provide a comprehensive and quantitative characterization of the molecular and morphological properties of human breast cancer cells (MDA-MB-231). The work also emphasizes the importance of establishing human-bias-free data processing pipelines to ensure that the extracted information from the multimodal datasets is correct and reliable. Here, we seek to establish a robust platform for cancer cell phenotyping that can be generalized to other types of cells. The versatility and sensitivity of this approach make it a potential candidate for a wide range of biomedical applications, from fundamental cell biology studies to diagnostics.